Bio-Rad Laboratories, Inc. (BIO)
USD 323.94
(-4.12%)
USD 323.94
(-4.12%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.43 Billion USD | -8.68% |
| 2022 | 1.56 Billion USD | -4.47% |
| 2021 | 1.64 Billion USD | 14.11% |
| 2020 | 1.43 Billion USD | 14.39% |
| 2019 | 1.25 Billion USD | 2.67% |
| 2018 | 1.22 Billion USD | 3.11% |
| 2017 | 1.18 Billion USD | 4.33% |
| 2016 | 1.13 Billion USD | 1.46% |
| 2015 | 1.12 Billion USD | -4.82% |
| 2014 | 1.17 Billion USD | 0.0% |
| 2013 | 1.17 Billion USD | 1.5% |
| 2012 | 1.16 Billion USD | -1.43% |
| 2011 | 1.17 Billion USD | 7.92% |
| 2010 | 1.09 Billion USD | 9.17% |
| 2009 | 999.84 Million USD | 3.88% |
| 2008 | 962.52 Million USD | 21.63% |
| 2007 | 791.36 Million USD | 11.06% |
| 2006 | 712.53 Million USD | 10.22% |
| 2005 | 646.48 Million USD | 5.97% |
| 2004 | 610.07 Million USD | 7.9% |
| 2003 | 565.39 Million USD | 10.97% |
| 2002 | 509.48 Million USD | 10.47% |
| 2001 | 461.17 Million USD | 8.3% |
| 2000 | 425.82 Million USD | 32.33% |
| 1999 | 321.8 Million USD | 23.58% |
| 1998 | 260.4 Million USD | 1.32% |
| 1997 | 257 Million USD | 0.9% |
| 1996 | 254.7 Million USD | 5.51% |
| 1995 | 241.4 Million USD | 11.6% |
| 1994 | 216.3 Million USD | 11.38% |
| 1993 | 194.2 Million USD | -5.73% |
| 1992 | 206 Million USD | 9.28% |
| 1991 | 188.5 Million USD | 8.71% |
| 1990 | 173.4 Million USD | 22.98% |
| 1989 | 141 Million USD | 20.1% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 326.46 Million USD | -10.78% |
| 2024 Q3 | 354.8 Million USD | 0.05% |
| 2024 Q2 | 355.71 Million USD | 8.96% |
| 2023 Q3 | 335.68 Million USD | -7.39% |
| 2023 Q2 | 362.48 Million USD | 0.02% |
| 2023 FY | 1.43 Billion USD | -8.68% |
| 2023 Q4 | 365.9 Million USD | 9.0% |
| 2023 Q1 | 362.41 Million USD | -8.73% |
| 2022 Q2 | 395.98 Million USD | -1.88% |
| 2022 Q1 | 403.56 Million USD | 0.64% |
| 2022 FY | 1.56 Billion USD | -4.47% |
| 2022 Q4 | 397.09 Million USD | 6.23% |
| 2022 Q3 | 373.79 Million USD | -5.6% |
| 2021 FY | 1.64 Billion USD | 14.11% |
| 2021 Q1 | 400.62 Million USD | -12.94% |
| 2021 Q2 | 401.59 Million USD | 0.24% |
| 2021 Q3 | 437.43 Million USD | 8.92% |
| 2021 Q4 | 401 Million USD | -8.33% |
| 2020 Q4 | 460.15 Million USD | 25.28% |
| 2020 Q3 | 367.31 Million USD | 25.37% |
| 2020 Q2 | 292.98 Million USD | -7.68% |
| 2020 Q1 | 317.36 Million USD | -3.96% |
| 2020 FY | 1.43 Billion USD | 14.39% |
| 2019 Q2 | 307.76 Million USD | -1.28% |
| 2019 Q4 | 330.43 Million USD | 7.63% |
| 2019 Q1 | 311.76 Million USD | -6.6% |
| 2019 Q3 | 307.02 Million USD | -0.24% |
| 2019 FY | 1.25 Billion USD | 2.67% |
| 2018 Q3 | 286.71 Million USD | -4.96% |
| 2018 Q4 | 333.77 Million USD | 16.41% |
| 2018 FY | 1.22 Billion USD | 3.11% |
| 2018 Q1 | 302.2 Million USD | -11.01% |
| 2018 Q2 | 301.66 Million USD | -0.18% |
| 2017 Q3 | 304.52 Million USD | 11.42% |
| 2017 Q4 | 339.59 Million USD | 11.52% |
| 2017 Q1 | 269.98 Million USD | -14.11% |
| 2017 FY | 1.18 Billion USD | 4.33% |
| 2017 Q2 | 273.29 Million USD | 1.23% |
| 2016 Q4 | 314.35 Million USD | 12.48% |
| 2016 FY | 1.13 Billion USD | 1.46% |
| 2016 Q2 | 280.23 Million USD | 6.14% |
| 2016 Q1 | 264.02 Million USD | -14.42% |
| 2016 Q3 | 279.46 Million USD | -0.27% |
| 2015 FY | 1.12 Billion USD | -4.82% |
| 2015 Q2 | 279.59 Million USD | 3.51% |
| 2015 Q3 | 263.45 Million USD | -5.77% |
| 2015 Q4 | 308.51 Million USD | 17.1% |
| 2015 Q1 | 270.1 Million USD | -14.9% |
| 2014 FY | 1.17 Billion USD | 0.0% |
| 2014 Q4 | 317.41 Million USD | 9.99% |
| 2014 Q2 | 297.24 Million USD | 7.97% |
| 2014 Q1 | 275.28 Million USD | -14.7% |
| 2014 Q3 | 288.57 Million USD | -2.92% |
| 2013 Q1 | 271.41 Million USD | -15.46% |
| 2013 Q2 | 300.1 Million USD | 10.57% |
| 2013 Q3 | 284.21 Million USD | -5.29% |
| 2013 FY | 1.17 Billion USD | 1.5% |
| 2013 Q4 | 322.74 Million USD | 13.56% |
| 2012 FY | 1.16 Billion USD | -1.43% |
| 2012 Q2 | 287.9 Million USD | 3.34% |
| 2012 Q1 | 278.58 Million USD | -10.41% |
| 2012 Q4 | 321.05 Million USD | 17.38% |
| 2012 Q3 | 273.51 Million USD | -5.0% |
| 2011 FY | 1.17 Billion USD | 7.92% |
| 2011 Q3 | 296.17 Million USD | 1.04% |
| 2011 Q2 | 293.13 Million USD | 5.59% |
| 2011 Q4 | 310.96 Million USD | 4.99% |
| 2011 Q1 | 277.61 Million USD | -7.38% |
| 2010 FY | 1.09 Billion USD | 9.17% |
| 2010 Q2 | 268.3 Million USD | 4.35% |
| 2010 Q1 | 257.12 Million USD | -4.22% |
| 2010 Q3 | 266.33 Million USD | -0.74% |
| 2010 Q4 | 299.72 Million USD | 12.54% |
| 2009 FY | 999.84 Million USD | 3.88% |
| 2009 Q4 | 268.46 Million USD | 3.06% |
| 2009 Q3 | 260.51 Million USD | 7.67% |
| 2009 Q2 | 241.96 Million USD | 5.71% |
| 2009 Q1 | 228.9 Million USD | -7.21% |
| 2008 Q3 | 240.54 Million USD | -3.17% |
| 2008 FY | 962.52 Million USD | 21.63% |
| 2008 Q4 | 246.67 Million USD | 2.55% |
| 2008 Q1 | 226.88 Million USD | -2.89% |
| 2008 Q2 | 248.42 Million USD | 9.49% |
| 2007 Q4 | 233.63 Million USD | 24.04% |
| 2007 Q2 | 189.99 Million USD | 5.91% |
| 2007 Q1 | 179.38 Million USD | -3.33% |
| 2007 FY | 791.36 Million USD | 11.06% |
| 2007 Q3 | 188.35 Million USD | -0.86% |
| 2006 Q4 | 185.55 Million USD | 11.25% |
| 2006 Q3 | 166.78 Million USD | -9.68% |
| 2006 Q2 | 184.66 Million USD | 5.2% |
| 2006 Q1 | 175.52 Million USD | 7.93% |
| 2006 FY | 712.53 Million USD | 10.22% |
| 2005 FY | 646.48 Million USD | 5.97% |
| 2005 Q4 | 162.62 Million USD | 3.71% |
| 2005 Q3 | 156.81 Million USD | -2.38% |
| 2005 Q2 | 160.64 Million USD | -3.46% |
| 2005 Q1 | 166.4 Million USD | -1.15% |
| 2004 Q2 | 149.66 Million USD | -0.74% |
| 2004 Q4 | 168.33 Million USD | 17.87% |
| 2004 Q3 | 142.81 Million USD | -4.58% |
| 2004 Q1 | 150.77 Million USD | 1.29% |
| 2004 FY | 610.07 Million USD | 7.9% |
| 2003 Q4 | 148.85 Million USD | 8.32% |
| 2003 Q3 | 137.42 Million USD | 0.75% |
| 2003 Q2 | 136.4 Million USD | -4.42% |
| 2003 Q1 | 142.71 Million USD | 4.29% |
| 2003 FY | 565.39 Million USD | 10.97% |
| 2002 FY | 509.48 Million USD | 10.47% |
| 2002 Q4 | 136.84 Million USD | 6.06% |
| 2002 Q3 | 129.02 Million USD | 5.52% |
| 2002 Q2 | 122.27 Million USD | 0.77% |
| 2002 Q1 | 121.34 Million USD | -9.38% |
| 2001 FY | 461.17 Million USD | 8.3% |
| 2001 Q4 | 133.9 Million USD | 26.1% |
| 2001 Q1 | 121.65 Million USD | 12.08% |
| 2001 Q3 | 106.18 Million USD | -3.24% |
| 2001 Q2 | 109.74 Million USD | -9.79% |
| 2000 Q1 | 107.65 Million USD | -0.41% |
| 2000 Q4 | 108.54 Million USD | 7.79% |
| 2000 Q3 | 100.7 Million USD | -7.56% |
| 2000 Q2 | 108.93 Million USD | 1.19% |
| 2000 FY | 425.82 Million USD | 32.33% |
| 1999 Q1 | 75.4 Million USD | 10.07% |
| 1999 Q3 | 67.4 Million USD | -4.8% |
| 1999 FY | 321.8 Million USD | 23.58% |
| 1999 Q4 | 108.1 Million USD | 60.39% |
| 1999 Q2 | 70.8 Million USD | -6.1% |
| 1998 Q2 | 64 Million USD | -7.51% |
| 1998 FY | 260.4 Million USD | 1.32% |
| 1998 Q4 | 68.5 Million USD | 16.7% |
| 1998 Q1 | 69.2 Million USD | 1.47% |
| 1998 Q3 | 58.7 Million USD | -8.28% |
| 1997 Q1 | 66.4 Million USD | -0.9% |
| 1997 FY | 257 Million USD | 0.9% |
| 1997 Q4 | 68.2 Million USD | 15.79% |
| 1997 Q3 | 58.9 Million USD | -7.39% |
| 1997 Q2 | 63.6 Million USD | -4.22% |
| 1996 Q2 | 62.2 Million USD | -5.04% |
| 1996 Q1 | 65.5 Million USD | 2.99% |
| 1996 FY | 254.7 Million USD | 5.51% |
| 1996 Q4 | 67 Million USD | 11.3% |
| 1996 Q3 | 60.2 Million USD | -3.22% |
| 1995 Q3 | 56.9 Million USD | -6.11% |
| 1995 Q2 | 60.6 Million USD | 0.5% |
| 1995 FY | 241.4 Million USD | 11.6% |
| 1995 Q1 | 60.3 Million USD | 4.87% |
| 1995 Q4 | 63.6 Million USD | 11.78% |
| 1994 FY | 216.3 Million USD | 11.38% |
| 1994 Q3 | 51.7 Million USD | -1.52% |
| 1994 Q2 | 52.5 Million USD | -3.85% |
| 1994 Q1 | 54.6 Million USD | 10.75% |
| 1994 Q4 | 57.5 Million USD | 11.22% |
| 1993 FY | 194.2 Million USD | -5.73% |
| 1993 Q1 | 49.7 Million USD | -6.75% |
| 1993 Q3 | 46.2 Million USD | -5.71% |
| 1993 Q4 | 49.3 Million USD | 6.71% |
| 1993 Q2 | 49 Million USD | -1.41% |
| 1992 FY | 206 Million USD | 9.28% |
| 1992 Q4 | 53.3 Million USD | 9.9% |
| 1992 Q3 | 48.5 Million USD | -4.53% |
| 1992 Q2 | 50.8 Million USD | -4.33% |
| 1992 Q1 | 53.1 Million USD | 7.93% |
| 1991 FY | 188.5 Million USD | 8.71% |
| 1991 Q3 | 46 Million USD | 0.66% |
| 1991 Q1 | 47.7 Million USD | 0.0% |
| 1991 Q2 | 45.7 Million USD | -4.19% |
| 1991 Q4 | 49.2 Million USD | 6.96% |
| 1990 Q3 | 41.2 Million USD | -3.96% |
| 1990 FY | 173.4 Million USD | 22.98% |
| 1990 Q1 | 41.6 Million USD | 10.05% |
| 1990 Q4 | 47.7 Million USD | 15.78% |
| 1990 Q2 | 42.9 Million USD | 3.13% |
| 1989 Q1 | 56.3 Million USD | 5.63% |
| 1989 Q2 | 35.4 Million USD | -37.12% |
| 1989 Q3 | 33.2 Million USD | -6.21% |
| 1989 Q4 | 37.8 Million USD | 13.86% |
| 1989 FY | 141 Million USD | 20.1% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Abbott Laboratories | 22.13 Billion USD | 93.533% |
| Allurion Technologies Inc. | 41.49 Million USD | -3349.276% |
| Artivion, Inc. | 229.17 Million USD | -524.562% |
| Avanos Medical, Inc. | 379.7 Million USD | -276.968% |
| Butterfly Network, Inc. | 16.85 Million USD | -8391.611% |
| Butterfly Network, Inc. | 16.85 Million USD | -8391.611% |
| Boston Scientific Corporation | 9.89 Billion USD | 85.535% |
| Perspective Therapeutics, Inc. | 1.63 Million USD | -87497.674% |
| CONMED Corporation | 643.06 Million USD | -122.581% |
| Edwards Lifesciences Corporation | 4.62 Billion USD | 69.052% |
| Paragon 28, Inc. | 172.79 Million USD | -728.368% |
| Glaukos Corporation | 239.13 Million USD | -498.549% |
| Globus Medical, Inc. | 1.02 Billion USD | -40.287% |
| Inspire Medical Systems, Inc. | 528.22 Million USD | -170.974% |
| Integer Holdings Corporation | 418.28 Million USD | -242.191% |
| Medtronic plc | 19.45 Billion USD | 92.642% |
| Nevro Corp. | 290.06 Million USD | -393.465% |
| Owlet, Inc. | 22.58 Million USD | -6237.035% |
| Penumbra, Inc. | 682.64 Million USD | -109.677% |
| Vicarious Surgical Inc. | -1.85 Million USD | 77303.128% |
| Smith & Nephew plc | 3.7 Billion USD | 61.325% |
| Sonendo, Inc. | 10.72 Million USD | -13249.618% |
| STERIS plc | 2.23 Billion USD | 35.929% |
| Stryker Corporation | 13.05 Billion USD | 89.039% |
| Vapotherm, Inc. | 28.28 Million USD | -4960.8% |
| Zimmer Biomet Holdings, Inc. | 5.31 Billion USD | 73.046% |